Molecular signature of patients with pre-treated urothelial carcinoma (UC) achieving extreme responses to pazopanib (PZP) salvage therapy Meeting Abstract

  

Authors:	Pinciroli, P.; Iyer, G.; Won, H. H.; Canevari, S.; Colecchia, M.; De Braud, F. G.; Daidone, M. G.; Giannatempo, P.; Raggi, D.; Pennati, M.; Zaffaroni, N.; Nicolai, N.; Salvioni, R.; Pierotti, M.; Solit, D. B.; Rosenberg, J. E.; Berger, M. F.; Necchi, A.
Abstract Title:	Molecular signature of patients with pre-treated urothelial carcinoma (UC) achieving extreme responses to pazopanib (PZP) salvage therapy
Meeting Title:	51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	15 Suppl.
Meeting Dates:	2015 May 29-Jun 2
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-05-20
Language:	English
ACCESSION:	WOS:000358036903064
PROVIDER:	wos
DOI:	10.1200/JCO.2015.33.15_suppl.e15514
Notes:	Meeting Abstract: e15514 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80552